Literature DB >> 24211039

The plasticity of human Treg and Th17 cells and its role in autoimmunity.

Markus Kleinewietfeld1, David A Hafler.   

Abstract

CD4(+) T helper cells are a central element of the adaptive immune system. They protect the organism against a wide range of pathogens and are able to initiate and control many immune reactions in combination with other cells of the adaptive and the innate immune system. Starting from a naive cell, CD4(+) T cells can differentiate into various effector cell populations with specialized function. This subset specific differentiation depends on numerous signals and the strength of stimulation. However, recent data have shown that differentiated CD4(+) T cell subpopulations display a high grade of plasticity and that their initial differentiation is not an endpoint of T cell development. In particular, FoxP3(+) regulatory T cells (Treg) and Th17 effector T cells demonstrate a high grade of plasticity, which allow a functional adaptation to various physiological situations during an immune response. However, the plasticity of Treg and Th17 cells might also be a critical factor for autoimmune disease. Here we discuss the recent developments in CD4(+) T cell plasticity with a focus on Treg and Th17 cells and its role in human autoimmune disease, in particular multiple sclerosis (MS).
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmunity; CD4(+) T cells; FoxP3; IL-17; T cell plasticity; Th17; Treg

Mesh:

Year:  2013        PMID: 24211039      PMCID: PMC3905679          DOI: 10.1016/j.smim.2013.10.009

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  149 in total

1.  CD147 (Basigin/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells.

Authors:  Therese Solstad; Simer Jit Bains; Johannes Landskron; Einar Martin Aandahl; Bernd Thiede; Kjetil Taskén; Knut Martin Torgersen
Journal:  Blood       Date:  2011-09-21       Impact factor: 22.113

2.  Rapid in vivo conversion of effector T cells into Th2 cells during helminth infection.

Authors:  Marc Panzer; Selina Sitte; Stefanie Wirth; Ingo Drexler; Tim Sparwasser; David Voehringer
Journal:  J Immunol       Date:  2011-12-07       Impact factor: 5.422

Review 3.  Multiple sclerosis.

Authors:  Alyssa Nylander; David A Hafler
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

4.  TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function.

Authors:  Mukanthu H Nyirenda; Lara Sanvito; Peter J Darlington; Kate O'Brien; Guang-Xian Zhang; Cris S Constantinescu; Amit Bar-Or; Bruno Gran
Journal:  J Immunol       Date:  2011-07-20       Impact factor: 5.422

5.  Romance of the three kingdoms: RORgammat allies with HIF1alpha against FoxP3 in regulating T cell metabolism and differentiation.

Authors:  Andy Tsun; Zuojia Chen; Bin Li
Journal:  Protein Cell       Date:  2011-10       Impact factor: 14.870

6.  Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.

Authors:  Kerstin Berer; Marsilius Mues; Michail Koutrolos; Zakeya Al Rasbi; Marina Boziki; Caroline Johner; Hartmut Wekerle; Gurumoorthy Krishnamoorthy
Journal:  Nature       Date:  2011-10-26       Impact factor: 49.962

7.  Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.

Authors:  H Jorn Bovenschen; Peter C van de Kerkhof; Piet E van Erp; Rob Woestenenk; Irma Joosten; Hans J P M Koenen
Journal:  J Invest Dermatol       Date:  2011-06-09       Impact factor: 8.551

8.  Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.

Authors:  Christina E Zielinski; Federico Mele; Dominik Aschenbrenner; David Jarrossay; Francesca Ronchi; Marco Gattorno; Silvia Monticelli; Antonio Lanzavecchia; Federica Sallusto
Journal:  Nature       Date:  2012-04-26       Impact factor: 49.962

9.  Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1.

Authors:  Eric V Dang; Joseph Barbi; Huang-Yu Yang; Dilini Jinasena; Hong Yu; Ying Zheng; Zachary Bordman; Juan Fu; Young Kim; Hung-Rong Yen; Weibo Luo; Karen Zeller; Larissa Shimoda; Suzanne L Topalian; Gregg L Semenza; Chi V Dang; Drew M Pardoll; Fan Pan
Journal:  Cell       Date:  2011-08-25       Impact factor: 41.582

10.  Response to self antigen imprints regulatory memory in tissues.

Authors:  Michael D Rosenblum; Iris K Gratz; Jonathan S Paw; Karen Lee; Ann Marshak-Rothstein; Abul K Abbas
Journal:  Nature       Date:  2011-11-27       Impact factor: 49.962

View more
  153 in total

Review 1.  Immune cell interplay in colorectal cancer prognosis.

Authors:  Samuel E Norton; Kirsten A Ward-Hartstonge; Edward S Taylor; Roslyn A Kemp
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

Review 2.  T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells.

Authors:  Bruce M Hall
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-15       Impact factor: 8.237

Review 3.  Dietary factors in rheumatic autoimmune diseases: a recipe for therapy?

Authors:  Shani Dahan; Yahel Segal; Yehuda Shoenfeld
Journal:  Nat Rev Rheumatol       Date:  2017-04-13       Impact factor: 20.543

Review 4.  Th17 cells and Tregs: unlikely allies.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  J Leukoc Biol       Date:  2014-02-21       Impact factor: 4.962

Review 5.  Modulating the Immune Response Towards a Neuroregenerative Peri-injury Milieu After Cerebral Hemorrhage.

Authors:  Damon Klebe; Devin McBride; Jerry J Flores; John H Zhang; Jiping Tang
Journal:  J Neuroimmune Pharmacol       Date:  2015-05-07       Impact factor: 4.147

Review 6.  Cardiac Autoimmunity: Myocarditis.

Authors:  William Bracamonte-Baran; Daniela Čiháková
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

7.  Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.

Authors:  M Rita I Young; Corinne A Levingston; Sara D Johnson
Journal:  Int J Cancer       Date:  2016-01-28       Impact factor: 7.396

8.  An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy.

Authors:  Chie Miyabe; Yoshishige Miyabe; Klemen Strle; Nancy D Kim; John H Stone; Andrew D Luster; Sebastian Unizony
Journal:  Ann Rheum Dis       Date:  2016-12-07       Impact factor: 19.103

Review 9.  Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.

Authors:  Laurent Meijer; Deborah J Nelson; Vladimir Riazanski; Aida G Gabdoulkhakova; Geneviève Hery-Arnaud; Rozenn Le Berre; Nadège Loaëc; Nassima Oumata; Hervé Galons; Emmanuel Nowak; Laetitia Gueganton; Guillaume Dorothée; Michaela Prochazkova; Bradford Hall; Ashok B Kulkarni; Robert D Gray; Adriano G Rossi; Véronique Witko-Sarsat; Caroline Norez; Frédéric Becq; Denis Ravel; Dominique Mottier; Gilles Rault
Journal:  J Innate Immun       Date:  2016-03-18       Impact factor: 7.349

Review 10.  Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.

Authors:  Eugene Y Kim; Kamal D Moudgil
Journal:  Cytokine       Date:  2017-04-25       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.